Shopping Cart
- Remove All
- Your shopping cart is currently empty
Lapaquistat acetate (TAK-475) is a squalene synthase inhibitor with potential anti-inflammatory activity. It mitigates statin-induced toxicity in human skeletal muscle cells and protects guinea pigs from simvastatin-induced myotoxicity, useful for research on hypercholesterolemia and HMG-CoA reductase deficiency.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $129 | In Stock | |
5 mg | $328 | In Stock | |
10 mg | $492 | In Stock |
Description | Lapaquistat acetate (TAK-475) is a squalene synthase inhibitor with potential anti-inflammatory activity. It mitigates statin-induced toxicity in human skeletal muscle cells and protects guinea pigs from simvastatin-induced myotoxicity, useful for research on hypercholesterolemia and HMG-CoA reductase deficiency. |
In vitro | Lapaquistat acetate (0-1000 nmol/L,24h) inhibited LPS-stimulated IL-1β production in MKD-like THP-1 cells. [2] |
In vivo | Lapaquistat acetate (100 or 200 mg/kg/ day) for 32 weeks increased collagen concentration and transformed coronary plaque into fibromuscular plaque in male WHHLMI rabbits. [1] |
Alias | TAK-475, TAK475 |
Molecular Weight | 645.14 |
Formula | C33H41ClN2O9 |
Cas No. | 189060-13-7 |
Smiles | O(C)C1=C([C@@H]2C=3C(N(CC(COC(C)=O)(C)C)C(=O)[C@@H](CC(=O)N4CCC(CC(O)=O)CC4)O2)=CC=C(Cl)C3)C=CC=C1OC |
Relative Density. | 1.246 g/cm3 (Predicted) |
Storage | keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||
Solubility Information | DMSO: 1 mg/mL (1.55 mM), Sonication is recommended. | ||||||||||
Solution Preparation Table | |||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.